Sanofi (SNY) Shares Sold by Macnealy Hoover Investment Management Inc.

Macnealy Hoover Investment Management Inc. cut its position in shares of Sanofi (NYSE:SNY) by 0.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,090 shares of the company’s stock after selling 80 shares during the period. Macnealy Hoover Investment Management Inc.’s holdings in Sanofi were worth $531,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Pennsylvania Trust Co boosted its stake in shares of Sanofi by 0.4% in the second quarter. Pennsylvania Trust Co now owns 8,314 shares of the company’s stock worth $402,000 after buying an additional 37 shares during the period. Weik Investment Services Inc. boosted its stake in shares of Sanofi by 0.9% in the first quarter. Weik Investment Services Inc. now owns 5,895 shares of the company’s stock worth $267,000 after buying an additional 50 shares during the period. Financial Advisors Network Inc. boosted its stake in shares of Sanofi by 1.0% in the first quarter. Financial Advisors Network Inc. now owns 8,282 shares of the company’s stock worth $409,000 after buying an additional 84 shares during the period. First City Capital Management Inc. boosted its stake in shares of Sanofi by 0.3% in the first quarter. First City Capital Management Inc. now owns 38,289 shares of the company’s stock worth $1,733,000 after buying an additional 100 shares during the period. Finally, Argent Trust Co boosted its stake in shares of Sanofi by 1.4% in the first quarter. Argent Trust Co now owns 8,015 shares of the company’s stock worth $363,000 after buying an additional 113 shares during the period. 9.96% of the stock is owned by hedge funds and other institutional investors.

Sanofi (SNY) traded up 0.30% on Friday, reaching $47.55. 717,957 shares of the company’s stock were exchanged. Sanofi has a 1-year low of $36.81 and a 1-year high of $50.24. The stock’s 50 day moving average price is $47.99 and its 200 day moving average price is $46.11. The firm has a market capitalization of $119.42 billion, a price-to-earnings ratio of 11.23 and a beta of 0.88.

Sanofi (NYSE:SNY) last posted its quarterly earnings results on Monday, July 31st. The company reported $0.74 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.74. Sanofi had a net margin of 25.89% and a return on equity of 25.34%. The company had revenue of $8.66 billion for the quarter, compared to the consensus estimate of $8.71 billion. Sanofi’s revenue was down 2.3% on a year-over-year basis. On average, analysts expect that Sanofi will post $3.26 earnings per share for the current year.

WARNING: This report was first posted by BNB Daily and is the property of of BNB Daily. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/14/macnealy-hoover-investment-management-inc-has-531000-stake-in-sanofi-sny-updated-updated-updated.html.

A number of equities research analysts recently weighed in on the stock. BidaskClub cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Argus boosted their price target on shares of Sanofi from $50.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, June 9th. Zacks Investment Research raised shares of Sanofi from a “hold” rating to a “buy” rating and set a $55.00 price target for the company in a research report on Friday, June 2nd. Berenberg Bank cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Finally, TheStreet upgraded shares of Sanofi from a “c+” rating to a “b-” rating in a research note on Monday, April 24th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $63.75.

Sanofi Company Profile

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Institutional Ownership by Quarter for Sanofi (NYSE:SNY)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply